{{Rsnum
|rsid=1624395
|Gene=IRAK3
|Chromosome=12
|position=66224436
|Orientation=plus
|GMAF=0.4284
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=IRAK3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 18.6 | 49.6 | 31.9
| HCB | 30.7 | 46.7 | 22.6
| JPT | 28.3 | 52.2 | 19.5
| YRI | 28.6 | 45.6 | 25.9
| ASW | 15.8 | 57.9 | 26.3
| CHB | 30.7 | 46.7 | 22.6
| CHD | 31.2 | 56.0 | 12.8
| GIH | 8.9 | 46.5 | 44.6
| LWK | 21.8 | 56.4 | 21.8
| MEX | 5.2 | 32.8 | 62.1
| MKK | 14.1 | 50.6 | 35.3
| TSI | 12.7 | 50.0 | 37.3
| HapMapRevision=28
}}{{omim
|desc=ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5
|id=611064
|rsnum=1624395
}}

{{omim
|desc=INTERLEUKIN 1 RECEPTOR-ASSOCIATED KINASE 3; IRAK3
|id=604459
|rsnum=1624395
}}

{{PMID Auto
|PMID=17503328
|Title=IRAK-M is involved in the pathogenesis of early-onset persistent asthma.
|OA=1
}}

{{PMID Auto
|PMID=22634523
|Title=Association study of IRAK-M and SIGIRR genes with SLE in a large European-descent population.
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}